Cipla Ltd launches copy of GSK’s top asthma drug in Germany, Sweden – Economic Times


Economic Times

Cipla Ltd launches copy of GSK's top asthma drug in Germany, Sweden
Economic Times
MUMBAI: Cipla Ltd has launched an anti-asthma inhaler in Germany and Sweden that is a generic version of GlaxoSmithKline Plc's Advair, a move that will further dent sales of the British firm's top-selling product. Cipla's drug will be marketed under

View full post on asthma – Google News

India’s Cipla launches copy of GSK’s top asthma drug in Germany, Sweden – Reuters


Economic Times

India's Cipla launches copy of GSK's top asthma drug in Germany, Sweden
Reuters
MUMBAI (Reuters) – India's Cipla Ltd has launched an anti-asthma inhaler in Germany and Sweden that is a generic version of GlaxoSmithKline Plc's Advair, a move that will further dent sales of the British firm's top-selling product. Cipla's drug will
Cipla targets US with asthma, HIV drugsMoneyweb.co.za

all 22 news articles »

View full post on asthma – Google News

India’s Cipla Launches Copy Of GSK’s Top Asthma Drug In Germany, Sweden – Business Insider


Economic Times

India's Cipla Launches Copy Of GSK's Top Asthma Drug In Germany, Sweden
Business Insider
MUMBAI (Reuters) – India's Cipla Ltd has launched an anti-asthma inhaler in Germany and Sweden that is a generic version of GlaxoSmithKline Plc's Advair, a move that will further dent sales of the British firm's top-selling product. Cipla's drug will
Cipla launches Serroflo in Germany and Sweden with affordable high quality pharmabiz.com

all 6 news articles »

View full post on asthma – Google News

Ventura bags major US partner for COPD/asthma combo copy – Pharma Times

Ventura bags major US partner for COPD/asthma combo copy
Pharma Times
division of an undisclosed leading international pharmaceutical company" for VR315, a combination therapy for chronic obstructive pulmonary disease and asthma that is widely thought to be a generic version of GlaxoSmithKline's blockbuster Advair.
Vectura Signs Up US Partner For VR315 Lung DrugNASDAQ
Vectura signs US license agreement for VR315 productStock Market Wire
Vectura gets new US partner for copy of lung drugReuters
The Pharma Letter –Pharmaceutical Business Review
all 13 news articles »

View full post on asthma – Google News

Sweden approves copy of GSK asthma blockbuster – FiercePharma

Sweden approves copy of GSK asthma blockbuster
FiercePharma
Swedish regulators have approved a knock-off version of the asthma drug, which brought in more than $8 billion in 2010 sales for GSK, paving the way for it to be sold in Germany, Italy, Portugal, Hungary and the Czech and Slovak Republics,
Glaxo's Advair Faces Sales Decline on Swedish Generic ApprovalBloomberg
Glaxo's Advair Faces Sales Decline on Swedish Generic ApprovalSan Francisco Chronicle

all 4 news articles »

View full post on asthma – Google News